发明申请
US20120148613A1 MULTIVALENT ENTRAIN-AND-AMPLIFY IMMUNOTHERAPEUTICS FOR CARCINOMA
审中-公开
多发性放射治疗和放大免疫球蛋白
- 专利标题： MULTIVALENT ENTRAIN-AND-AMPLIFY IMMUNOTHERAPEUTICS FOR CARCINOMA
- 专利标题（中）： 多发性放射治疗和放大免疫球蛋白
-
申请号： US13336523申请日： 2011-12-23
-
公开(公告)号： US20120148613A1公开(公告)日： 2012-06-14
- 发明人: Adrian Ion Bot , Chih-Sheng Chiang , David C. Diamond , Jian Gong , Kent Andrew Smith , Liping Liu , Xiping Liu , Zhiyong Qiu
- 申请人： Adrian Ion Bot , Chih-Sheng Chiang , David C. Diamond , Jian Gong , Kent Andrew Smith , Liping Liu , Xiping Liu , Zhiyong Qiu
- 申请人地址： US CA Valencia
- 专利权人： MannKind Corporation
- 当前专利权人： MannKind Corporation
- 当前专利权人地址： US CA Valencia
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; A61P35/00
摘要：
The present invention provides a method of treating a cell proliferative disease such as cancer by providing to a subject in need thereof an immunogenic composition comprising plasmid and peptide(s) or analogues thereof. In embodiments of the present invention there is provided methods and compositions for inducing, entraining, and/or amplifying the immune response to MHC class-I restricted epitopes of carcinoma antigens to generate an effective anti-cancer immune response.
信息查询
